12-Month Lobbying Summary - Organization

AstraZeneca Canada Inc. / Gaby Bourbara, President

Registration Summary

Currently active - Last Updated: 2024-07-23

Who is lobbying?

AstraZeneca Canada Inc. (Address & business activities)

Gaby Bourbara, President

Senior Officer in previous versions
- Kiersten Combs, President

Government Funding

Did AstraZeneca Canada Inc. request or receive government funding within the last 12 months? No

Coalition Members Information

AstraZeneca Canada Inc. is not a coalition member.

Direct Interests of the Lobbying Activity

Affiliates

AstraZeneca Canada Inc. has the following affiliates that could have a direct interest in the outcome of the lobbying activities:

AstraZeneca plc (Address information)

Other Affiliates

The activities of AstraZeneca Canada Inc. are not controlled or directed by another person or organization with a direct interest in the outcome of this undertaking

Contributors with a Direct Interest in the Outcome

No person or organization contributed over $1000CDN, within the preceding 12 months, toward the lobbying activity on behalf of AstraZeneca Canada Inc.:

What is being lobbied?

Subject Matter of the Lobbying Activities

Details Regarding the Identified Subject Matter

Will any of the lobbyists listed within this registration arrange a meeting between a public office holder and any other individual for the purpose of attempting to influence any of the matters listed below:

Yes

Specific Topics of Lobbying Communications	Intended Outcomes	Associated Subject Matters
Discussions with BC Government officials, organizations and elected representatives to obtain public funding for AZ's innovation pharmaceuticals and biopharmaceuticals. To encourage the BC government to recognize the importance of investments made in R&D within the province and how these investments lead to the health development of BC's health ecosystem.	Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Economic Development and Trade
Discussions with BC government officials/organizations and elected representative to obtain public reimbursement of AstraZeneca Canada (AZC) innovative treatments for BC Citizens that require access to these treatments, including health system resilience policy and environmental considerations in health care. These discussions will take place with BC government bodies as Pharmacare, the BC Cancer Agency and First Nations Health Authority. This will include discussions on how best to conclude Product Listing Agreement and health care delivery discussions with each of these public entities.	Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Health
Discussions with BC government officials/organizations and elected representative to obtain public reimbursement of AstraZeneca Canada (AZC) innovative treatments for BC Citizens that require access to these treatments. These discussions will take place with BC government funded programs such as the provincial Health Authorities including PHSA	Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Hospitals
Discussions with BC government officials and organizations including elected representatives to encourage the BC government to recognize the importance of AstraZeneca Canada's and the Biopharmaceutical investments in Research and Development in BC's healthcare bioscience ecosystem, and to providing innovative approaches to management of the health care system.	Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Industry
Discussions with BC government officials and organizations including elected representatives to encourage the BC government to recognize the importance of AstraZeneca Canada's investments in Research and Development in BC's healthcare bioscience ecosystem, and to providing innovative approaches to management of the health care system.	Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Science and Technology
Discussions with BC Government officials including the Ministry of Finance , organizations and elected representatives to discuss funding for AZ's innovation pharmaceuticals and biopharmaceuticals. To encourage the BC government and various ministries to recognize the importance of investments mad in R&D within the province and how these investments lead to the health development of BC's health ecosystem.	Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Finances and Budgets
Provide supply chain availability updates on AstraZeneca Canada medicines including vaccines, deemed essential for COVID-19 acute and community care.	Development of any legislative proposal by the government of British Columbia, a Provincial entity or a member of the Legislative Assembly Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	COVID-19

Subject matter details in previous versions

Specific Topics of Lobbying Communications	Intended Outcomes	Associated Subject Matters
Discussions with BC Government officials, organizations and elected representatives to obtain pubic funding for AZ's innovation pharmaceuticals and biopharmaceuticals. To encourage the BC government to recognize the importance of investments mad in R&D within the province and how these investments lead to the health development of BC's health ecosystem.	Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Economic Development and Trade
Discussions with BC government officials/organizations and elected representative to obtains public reimbursement of AstraZeneca Canada (AZC) innovative treatments for BC Citizens that require access to these treatments, including health system resilience policy and environmental considerations in health care. These discussions will take place with BC government bodies as Pharmacare, the BC Cancer Agency and First Nations Health Authority. This will include discussions on how best to conclude Product Listing Agreement and health care delivery discussions with each of these public entities.	Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Health
Seek reimbursement for AZ's mental health and addiction pharmaceuticals through BC Pharmacare.	Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Mental Health and Addictions

Gifts or benefits provided by the organization

Gifts or Benefits Provided to Public Officer Holders
Name	Gift or Benefit Description	Circumstance	Date Promised	Value Promised	Date Given	Value Given
No Records

Who is being lobbied?

Ministries/Provincial Entities

Finance
Fraser Health Authority
Health
Interior Health Authority
Jobs, Economic Development and Innovation
Member(s) of the BC Legislative Assembly
Mental Health and Addictions
Nisga'a Valley Health Authority
Northern Health Authority
Office of the Premier
Parliamentary Secretary for Environment
Provincial Health Services Authority
Vancouver Coastal Health Authority
Vancouver Island Health Authority

Who are the lobbyists?

In-house Lobbyists

Lobbyist

Contributions

Derek Badger
Subscribes to a Code of Conduct: No
Former Public Office Holder in BC: No

Lobbied a member of the Legislative Assembly, including a Minister or Premier, on behalf of this organization on or after 2020-09-21 and before 2024-09-21: No
Lobbied or plans to lobby a member of the Legislative Assembly, including a Minister or Premier, on behalf of this organization, on or after 2024-09-21: Yes	Political: No Sponsorship: No Recall: No

Jim Favaro
Subscribes to a Code of Conduct: No
Former Public Office Holder in BC: No

Lobbied a member of the Legislative Assembly, including a Minister or Premier, on behalf of this organization on or after 2020-09-21 and before 2024-09-21: No
Lobbied or plans to lobby a member of the Legislative Assembly, including a Minister or Premier, on behalf of this organization, on or after 2024-09-21: Yes	Political: No Sponsorship: No Recall: No

Jon Feairs
Subscribes to a Code of Conduct: No
Former Public Office Holder in BC: No

Lobbied a member of the Legislative Assembly, including a Minister or Premier, on behalf of this organization on or after 2020-09-21 and before 2024-09-21: No
Lobbied or plans to lobby a member of the Legislative Assembly, including a Minister or Premier, on behalf of this organization, on or after 2024-09-21: Yes	Political: No Sponsorship: No Recall: No

Ilias Iliopoulos
Subscribes to a Code of Conduct: No
Former Public Office Holder in BC: No

Lobbied a member of the Legislative Assembly, including a Minister or Premier, on behalf of this organization on or after 2020-09-21 and before 2024-09-21: No
Lobbied or plans to lobby a member of the Legislative Assembly, including a Minister or Premier, on behalf of this organization, on or after 2024-09-21: Yes	Political: No Sponsorship: No Recall: No

Gurvinder Kenth
Subscribes to a Code of Conduct: No
Former Public Office Holder in BC: No

Lobbied a member of the Legislative Assembly, including a Minister or Premier, on behalf of this organization on or after 2020-09-21 and before 2024-09-21: No
Lobbied or plans to lobby a member of the Legislative Assembly, including a Minister or Premier, on behalf of this organization, on or after 2024-09-21: Yes	Political: No Sponsorship: No Recall: No

Heather McDonald
Subscribes to a Code of Conduct: No
Former Public Office Holder in BC: No

Lobbied a member of the Legislative Assembly, including a Minister or Premier, on behalf of this organization on or after 2020-09-21 and before 2024-09-21: No
Lobbied or plans to lobby a member of the Legislative Assembly, including a Minister or Premier, on behalf of this organization, on or after 2024-09-21: Yes	Political: No Sponsorship: No Recall: No

Kevin McGuire
Subscribes to a Code of Conduct: No
Former Public Office Holder in BC: No

Lobbied a member of the Legislative Assembly, including a Minister or Premier, on behalf of this organization on or after 2020-09-21 and before 2024-09-21: No
Lobbied or plans to lobby a member of the Legislative Assembly, including a Minister or Premier, on behalf of this organization, on or after 2024-09-21: Yes	Political: No Sponsorship: No Recall: No

Gena Restivo
Subscribes to a Code of Conduct: No
Former Public Office Holder in BC: No

Lobbied a member of the Legislative Assembly, including a Minister or Premier, on behalf of this organization on or after 2020-09-21 and before 2024-09-21: No
Lobbied or plans to lobby a member of the Legislative Assembly, including a Minister or Premier, on behalf of this organization, on or after 2024-09-21: Yes	Political: No Sponsorship: No Recall: No

Noel Saraza
Subscribes to a Code of Conduct: No
Former Public Office Holder in BC: No

Lobbied a member of the Legislative Assembly, including a Minister or Premier, on behalf of this organization on or after 2020-09-21 and before 2024-09-21: No
Lobbied or plans to lobby a member of the Legislative Assembly, including a Minister or Premier, on behalf of this organization, on or after 2024-09-21: Yes	Political: No Sponsorship: No Recall: No

Lobbyists in previous versions

In-house Lobbyists
Lobbyist	BC Former Public Office Holder Positions	Contributions
Kiersten Combs	Former Public Office Holder in BC: No	Contributions: No

Registration number: 10233-204
View all registrations versions

Lobbying Activity Reports

What lobbying activities have taken place in the last 12 months?

What lobbying activities have taken place in the last 12 months?
Date	Arranging a Meeting	Lobbyists	Senior Public Office Holder, Position Title \| Ministry/Provincial Entity	Subject Matters
2024-11-27	Yes	Derek Badger	Mitch Moneo, Assistant Deputy Minister \| Pharmaceutical, Laboratory and Blood Services Division, Health	View
2024-09-19	Yes	Derek Badger	Ian Rongve, ADM \| Strategic Innovation, Health	View
2024-05-16	Yes	Derek Badger	Mitch Moneo, Assistant Deputy Minister \| Pharmaceutical, Laboratory&Blood Services, Provincial Health Services Authority	View
2024-03-06	Yes	Derek Badger	Honieh Barzegari, Ministerial Advisor \| Minister's Office, Jobs, Economic Development and Innovation	View

View all Lobbying Activity Reports

AstraZeneca Canada Inc. - Address & business activities

Address:

1004 Middlegate Road, Ste 5000
Mississauga, ON L4Y 1M4
Canada

Telephone number: 800-565-5877

Contact information in previous versions
- 1004 Middlegate Road, Ste 5000
  Mississauga, ON L4Y 1M4
  Canada
  
  Telephone number: 800-565-5877 Ext. 46883
- 1004 Middlegate Road, Ste 5000
  
  Mississauga, BC L4Y 1M4
  Canada
  
  Telephone number: 800-565-5877
- 1004 Middlegate Road, Ste 5000
  
  Mississauga, BC L4Y 1M4
  Canada
  
  Telephone number: 905-615-6883
- 1004 Middlegate Road, Ste 5000
  
  Mississauga, ON L4Y 1M4
  Canada
  
  Telephone number: 905-615-6883
- 1004 Middlegate Road
  
  Mississauga, ON L4Y 1M4
  Canada
  
  Telephone number: 905-615-6883
- 1004 Middlegate Road
  
  Mississauga, ON L4Y 1M4
  Canada
  
  Telephone number: 905-277-7111
- 1004 Middlegate Road
  
  Mississauga, ON L4Y 1M4
  Canada
  
  Telephone number: 905-615-6883
  
  Fax number: 905-277-5627

Description of Activities:
AstraZeneca is a global, innovation-driven biopharmaceutical business with a primary focus on the discovery, development and commercialization of prescription medicines for gastrointestinal, cardiovascular, neuroscience, respiratory and inflammation, oncology and infectious disease. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. AstraZeneca’s Canadian headquarters are located in Mississauga, Ontario. For more information, please visit the company’s website at www.astrazeneca.ca.

Descriptions of the organization's activity in previous versions:
- Focus on Innovative Life Sciences/Economic Development Policies; Health as an Economic Generator of Wealth in British Columbia; and Health Policy/Reimbursement decisions
- Focus on Innovative Life Sciences/Economic Development Policies; Health as an Economic Generator of Wealth in British Columbia; and Health Policy/Reimbursement decisions
- Focus on Innovative Life Sciences/Economic Development Policies, Health as an Economic Generator of Wealth in British Columbia and Health Policy/Reimbursement decisions

Date Modified:: 2024-12-13

Menus

www.lobbyistsregistrar.bc.ca

12-Month Lobbying Summary - Organization

AstraZeneca Canada Inc. / Gaby Bourbara, President

Who is lobbying?

AstraZeneca Canada Inc. (Address & business activities)

Government Funding

Coalition Members Information

Direct Interests of the Lobbying Activity

Affiliates

Other Affiliates

Contributors with a Direct Interest in the Outcome

What is being lobbied?

Details Regarding the Identified Subject Matter

Gifts or benefits provided by the organization

Who is being lobbied?

Ministries/Provincial Entities

Who are the lobbyists?

What lobbying activities have taken place in the last 12 months?

12-Month Lobbying Summary - Organization

AstraZeneca Canada Inc. / Gaby Bourbara, President

AstraZeneca Canada Inc. (Address & business activities)

Government Funding

Coalition Members Information

Direct Interests of the Lobbying Activity

Affiliates

Other Affiliates

Contributors with a Direct Interest in the Outcome

Details Regarding the Identified Subject Matter

Gifts or benefits provided by the organization

Ministries/Provincial Entities

AstraZeneca Canada Inc. - Address & business activities

AstraZeneca Canada Inc. / Gaby Bourbara, President

AstraZeneca plc